MAY 16-17, 2007

14TH & K STREETS, NW

WASHINGTON, DC

Workshop Presentations

Plenary Session Presentations

Welcome and Introductory Remarks – Dr. Joseph Piccotti (Pfizer)

Current Strategies for Evaluating Immune Status and Perceived Gaps – Nonclinical (Industry and Regulatory Perspectives) – Dr. Ken Hastings (U.S. Food & Drug Administration)

Current Strategies for Evaluating Immune Status and Perceived Gaps – Clinical (Industry and Regulatory Perspectives) – Dr. Ian Gourley (Wyeth Research)

Clinical Immunology Assessment in Relation to Drug Development –  Dr. Ronald Harbeck (National Jewish Medical and Research Center)

Results of HESI ITC Immunomodulators Survey – Dr. Ellen Evans (Schering-Plough Research Institute)

Instructions for Break-out Sessions – Dr. Joseph Piccotti

HESI Immunomodulators Immunotoxicity Assessment Survey

Break-out Sessions

Break-out Group I - Group Leader:  Dr. Thomas Kawabata; Rapporteur: Dr. Danuta Herzyk

Break-out Group II - Group Leader: Dr. Ken Hastings; Rapporteur:  Dr. Leigh Ann Burns-Naas

Break-out Group III - Group Leader:  Dr. Hervé Lebrec; Rapporteur:  Dr. Ellen Evans

Break-out Group IV - Group Leader:  Dr. Ian Gourley; Rapporteur:  Dr. Dan Wierda